Hanami Kentaro 花見健太郎

… Alternative Names

Researcher Number	50441853
Other IDs
Affiliation (Current)	2021: 産業医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2014 – 2019: 産業医科大学, 医学部, 助教 2009: 産業医大, 医学部, 研究員 2008: University of Occupational and Environmental Health, Japan, 医学部, 専門修練医
Review Section/Research Field	Principal Investigator Collagenous pathology/Allergology / 膠原病・アレルギー・感染症内科学 / Basic Section 54020:Connective tissue disease and allergy-related
Keywords	Principal Investigator 樹状細胞 / 破骨細胞 / ドパミン受容体シグナル / stat6 / Jak3 / 神経伝達物質 / 骨リモデリング / 抗原提示能 / シグナル伝達

関節リウマチにおける神経伝達物質ドパミンを起点とした病態解明と新規治療法の開発Principal InvestigatorOngoing
- Principal Investigator
  
  花見健太郎
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54020:Connective tissue disease and allergy-related
- Research Institution
  University of Occupational and Environmental Health, Japan
The mechanism of dendritic cell-derived osteoclasts in the pathogenesis of arthritis.Principal Investigator
- Principal Investigator
  
  Hanami Kentaro
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Collagenous pathology/Allergology
- Research Institution
  University of Occupational and Environmental Health, Japan
Dopamine receptor signaling regulates human osteoclastogenesis.Principal Investigator
- Principal Investigator
  
  HANAMI Kentaro
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Collagenous pathology/Allergology
- Research Institution
  University of Occupational and Environmental Health, Japan
樹状細胞Stat6制御による新規関節リウマチの治療の開発Principal Investigator
- Principal Investigator
  
  花見健太郎
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  膠原病・アレルギー・感染症内科学
- Research Institution
  University of Occupational and Environmental Health, Japan

All 2020 2019 2018 2017 2016 2015 2014

All Journal Article Presentation

[Journal Article] The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.2020
- Author(s)
  Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Kawabe A, Miyazaki Y, Inoue Y, Ueno M, Ohkubo N, Fujita Y, Tanaka Y.
- Journal Title
  
  Int J Rheum Dis.
  
  Volume: 23(4) Pages: 549-558
- DOI
  10.1111/1756-185x.13792
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08926
[Journal Article] 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.2020
- Author(s)
  Yamaguchi A, Hirata S, Kubo S, Fukuyo S, Hanami K, Nakano K, Nakayamada S, Saito K, Tanaka Y.
- Journal Title
  
  Mod Rheumatol.
  
  Volume: 15 Pages: 1-8
- DOI
  10.1080/14397595.2019.1702141
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08926
[Journal Article] Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.2020
- Author(s)
  Nakano K, Saito K, Nawata A, Hanami K, Kubo S, Miyagawa I, Fujino Y, Nakayamada S, Tanaka Y.
- Journal Title
  
  Mod Rheumatol.
  
  Volume: 27 Pages: 1-7
- DOI
  10.1080/14397595.2020.1741870
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08926
[Journal Article] Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.2019
- Author(s)
  Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Inoue Y, Ueno M, Tanaka Y.
- Journal Title
  
  Int J Rheum Dis.
  
  Volume: 22(3) Pages: 434-442
- DOI
  10.1111/1756-185x.13387
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09915
[Journal Article] Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis.2018
- Author(s)
  Ishikawa Y, Iwata S, Hanami K, Nawata A, Zhang M, Yamagata K, Hirata S, Sakata K, Todoroki Y, Nakano K, Nakayamada S, Satoh M, Tanaka Y.
- Journal Title
  
  Arthritis Res Ther.
  
  Volume: 20 Pages: 240-240
- DOI
  10.1186/s13075-018-1737-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09914, KAKENHI-PROJECT-16K09915
[Journal Article] Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matching.2018
- Author(s)
  Kubo S, Nakayamada S, Nakano K, Sawamukai N, Hirata S, Hanami K, Saito K1, Tanaka Y.
- Journal Title
  
  Clin Immunol.
  
  Volume: 191 Pages: 67-74
- DOI
  10.1016/j.clim.2018.03.018
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09915
[Journal Article] Pleurisy Caused by <i>Mycobacterium abscessus</i> in a Young Patient with Dermatomyositis: A Case Report and Brief Review of the Literature2018
- Author(s)
  Noguchi S, Hanami K, Miyata H, Torii R, Shimabukuro I, Kubo S, Obata H, Yoshii C, Yatera K.
- Journal Title
  
  Internal Medicine
  
  Volume: 57(7) Issue: 7 Pages: 997-1002
- DOI
  10.2169/internalmedicine.9537-17
- NAID
  130006602626
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2018-04-01
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09915
[Journal Article] Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients2017
- Author(s)
  Kubo S, Nakayamada S, Yoshikawa M, Miyazaki Y, Sakata K, Nakano K, Hanami K, Iwata S, Miyagawa I, Saito K, Tanaka Y.
- Journal Title
  
  Arthritis Rheumatol
  
  Volume: 69(10) Pages: 2029-2037
- DOI
  10.1002/art.40180
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09915, KAKENHI-PROJECT-17K10010, KAKENHI-PROJECT-17K16218
[Journal Article] Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.2016
- Author(s)
  Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y.
- Journal Title
  
  Mod Rheumatol.
  
  Volume: Mar 30 Pages: 1-7
- Data Source
  KAKENHI-PROJECT-26860764
[Journal Article] Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.2016
- Author(s)
  Kubo S, Nakayamada S, Nakano K, Hirata S, Fukuyo S, Miyagawa I, Hanami K, Saito K, Tanaka Y.
- Journal Title
  
  Ann Rheum Dis.
  
  Volume: Aug 5 Pages: 207784-207784
- DOI
  10.1136/annrheumdis-2015-207784
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26860764, KAKENHI-PROJECT-16K09915
[Journal Article] Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.2016
- Author(s)
  Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y.
- Journal Title
  
  Mod Rheumatol.
  
  Volume: 26 Pages: 850-856
- DOI
  10.3109/14397595.2016.1153449
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08956, KAKENHI-PROJECT-16K09915
[Journal Article] Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.2015
- Author(s)
  Tanaka Y, Hirata S, Kubo S, Fukuyo S, Hanami K, Sawamukai N, Nakano K, Nakayamada S, Yamaoka K, Sawamura F, Saito K.
- Journal Title
  
  Ann Rheum Dis.
  
  Volume: in press Pages: 389-95
- DOI
  10.1136/annrheumdis-2013-204016
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460713, KAKENHI-PROJECT-26860764
[Journal Article] Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment levels is predictive of DAS 28 remission with tocilizumab.2015
- Author(s)
  Hirata S, Marotta A, Gui Y, Hanami K, Tanaka Y.
- Journal Title
  
  Arthritis Res Ther.
  
  Volume: 17 Pages: 280-280
- DOI
  10.1186/s13075-015-0799-7
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25460713, KAKENHI-PROJECT-26860764
[Journal Article] Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.2014
- Author(s)
  Miyagawa I, Nakayamada S, Saito K, Hanami K, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y.
- Journal Title
  
  Mod Rheumatol.
  
  Volume: 24(3) Pages: 405-9
- DOI
  10.3109/14397595.2013.844294
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26860764
[Journal Article] Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.2014
- Author(s)
  Tanaka Y, Takeuchi T, Amano K, Saito K, Hanami K, Nawata M, Fukuyo S, Kameda H, Kaneko Y, Kurasawa T, Nagasawa H, Hoshi D, Sato E, Yamanaka H.
- Journal Title
  
  Mod Rheumatol.
  
  Volume: 24(3) Pages: 399-404
- DOI
  10.3109/14397595.2013.843757
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26860764
[Presentation] Serum 14-3-3η is a Modifiable, Mechanistic Biomarker that Predicts Tocilizumab Response2015
- Author(s)
  Kentaro Hanami, Shintaro Hirata, Anthony Marotta, Yoshiya Tanaka
- Organizer
  欧州リウマチ学会 (第16回)
- Place of Presentation
  ローマ（イタリア）
- Year and Date
  2015-06-10
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26860764
[Presentation] 血清14-3-3ηと関節リウマチの疾患活動性の関連についての検討2015
- Author(s)
  花見健太郎 , 平田信太郎 , 宮川一平 , 久保智史 , 福與俊介 , 澤向範文 , 中野和久 , 中山田真吾 , 齋藤和義 , 田中良哉
- Organizer
  日本リウマチ学会 (第59回)
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2015-04-23
- Data Source
  KAKENHI-PROJECT-26860764
[Presentation] 関節リウマチに対するTocilizumabとAdalimumab投与によるMBDAスコアの12バイオマーカーの挙動比較2015
- Author(s)
  花見健太郎 , 平田信太郎 , 宮川一平 , 久保智史 , 福與俊介 , 澤向範文 , 中野和久 , 中山田真吾 , 齋藤和義 , 田中良哉
- Organizer
  日本リウマチ学会 (第59回)
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2015-04-23
- Data Source
  KAKENHI-PROJECT-26860764

1. 久保智史 (70461548)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
2. 田中良哉 (30248562)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. YAMAGATA KAORU

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. HIRATA Shintaro

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
5. 中山田真吾

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Hanami Kentaro 花見 健太郎

HANAMI Kentaro 花見 健太郎

花見 健太郎 ハナミ ケンタロウ

Research Projects

Research Products

Co-Researchers

関節リウマチにおける神経伝達物質ドパミンを起点とした病態解明と新規治療法の開発Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The mechanism of dendritic cell-derived osteoclasts in the pathogenesis of arthritis.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Dopamine receptor signaling regulates human osteoclastogenesis.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

樹状細胞Stat6制御による新規関節リウマチの治療の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matching.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pleurisy Caused by <i>Mycobacterium abscessus</i> in a Young Patient with Dermatomyositis: A Case Report and Brief Review of the Literature2018

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.2016

Author(s)

Journal Title

Data Source

[Journal Article] Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.2016

Author(s)

Hanami Kentaro 花見健太郎

HANAMI Kentaro 花見健太郎

花見健太郎ハナミケンタロウ